Charles A. Weiss is a partner in Holland & Knight's New York office and head of the New York Intellectual Property Group. He concentrates his practice on technology-driven litigation, counseling and transactions, primarily in the pharmaceutical, chemical and biotechnology areas. He also counsels clients on questions of patent validity and infringement, and provides a litigator's perspective on prosecution matters.
Mr. Weiss litigates patent, trade secret, license and false advertising cases in diverse technical areas. He has handled cases over the years involving expression of recombinant proteins and antibodies, controlled release pharmaceuticals, medical diagnostic agents, endocrine and hormone products, nutritional supplements, industrial control systems, food chemistry, nucleic acid diagnostic assays and commercial detergents. He also has extensive experience in the investigation of product counterfeiting and pursuit of those responsible.
Mr. Weiss also has a diverse non-litigation practice focused on supporting transactions in which a substantial value is attributed to a party's patent position, such as its ability to exclude competitors or to bring its product to market free of meritorious infringement claims by others. He negotiates and drafts licenses and other agreements, including commercial collaboration, joint research and product acquisition agreements, and regularly advises financial professionals on the strength or vulnerability of a target company's patent positions.
Mr. Weiss also has experience in commercial matters, including corporate and securities transactions, contract litigation, insurance and banking disputes, construction litigation, accounting and attorney malpractice, and investigations of employee malfeasance and fraud. Mr. Weiss is an associate adjunct professor at Brooklyn Law School, where he designed and teaches a course on food and drug law.
Eric Huang is a partner in Quinn Emanuel's New York office. He represents both plaintiffs and defendants in intellectual property matters. He specializes in building patent infringement cases on either side of the “v” in highly technical subject matter. He has extensive experience litigating patent cases involving a wide range of technologies – smartphones, user interface software, touchscreen technology, circuits, semiconductor processing, spreading and modulation techniques used in wireless communication, various aspects of 3G and 4G cellular communications, error control coding including turbocodes and low density parity check codes, digital video compression, audio compression, pharmaceutical formulations, fiber optics, liquid crystal displays, mechanical measurement devices, electronic engine control, e-commerce, and computer systems.
His practice encompasses all aspects of case preparation, pre-trial discovery, expert preparation, trial preparation and trial in U.S. federal district courts and before the U.S. International Trade Commission. He served as a trial counsel for respondent Samsung in ITC investigation 337-TA-796 initiated by Apple against Samsung's smartphones, tablets and media players. The firm successfully defended against efforts to stop the importation of Samsung devices; to date, no Samsung device was excluded or seized as a result of any order from this investigation. Eric recently helped secure a very favorable jury verdict for Marvell Semiconductor in a case brought by France Telecom in San Francisco federal district court alleging infringement by Marvell’s 3G baseband chips. In addition to a favorable damages verdict of a fraction of the damages sought by plaintiff, the firm recently secured judgment for Marvell Semiconductor on post-trial motions in that case. Eric also has experience prosecuting patents and is admitted to the U.S. Patent & Trademark Office.
Eric’s representative clients include BlackBerry, California Institute of Technology, Canon, Marvell Semiconductor, MediaTek, Monolithic Power Systems, Motorola, Reliant Pharmaceuticals, Rovi, Samsung, and Sony.
Prior to joining Quinn Emanuel, Eric was an associate with the law firm of Fish & Neave and served as a law clerk to the Honorable Eric Bruggink on the U.S. Court of Federal Claims (1997-1998). He is a 1997 graduate of the George Washington University Law School, and has a materials science & engineering degree from the University of Michigan in Ann Arbor. Prior to law school, Eric worked for National Semiconductor in California as an electronic packaging engineer. He currently serves on the Board of Directors of the New York Lawyers for the Public Interest and the Board of Trustees for the Blue School, a private independent school in New York City.
John Hintz is a Shareholder in Maynard Cooper’s New York office and a member of the firm’s Intellectual Property Litigation and Intellectual Property Protection practice groups. He has more than 30 years of experience handling intellectual property matters, and in particular, patent litigation.
John has worked on all aspects of patent disputes and has litigated in federal courts throughout the country, at the Court of Appeals for the Federal Circuit, and at the International Trade Commission. John also has significant transactional, licensing, and counseling experience, including advising clients on the IP aspects of IPOs, mergers and acquisitions, and the transfer and licensing of IP assets.
His clients span a broad range of industries covering diverse technologies including search engines, financial services, semiconductors, barcode scanning, Internet-related businesses and technologies, telecommunications, LED and other lighting devices, computer simulations, commodity chemicals, polymers, process control instruments, medical devices, and life sciences.
John served as Samsung’s expert witness on U.S. law related to patents and patent licensing in disputes between Samsung and Apple in the Netherlands, France, Italy, Japan and Australia.
John began his IP career and became a partner at the preeminent IP litigation law firm Fish & Neave.
Karen Mangasarian is a partner and intellectual property lawyer with Foley & Lardner LLP. She counsels biotechnology, pharmaceutical, and other life sciences clients on all aspects of intellectual property, including procurement and management of worldwide patent rights, patent life cycle management, development of competitive patent strategies, licensing, IP due diligence, and validity, patentability, non-infringement, and freedom-to-operate analyses. She also has extensive experience in contentious patent matters, including interferences, re-examinations, oppositions, and litigation. Dr. Mangasarian has successfully worked with clients across a wide range of technology areas in life sciences including small molecule pharmaceuticals, pharmaceutical formulations, antibodies, protein therapeutics, CRISPR and diagnostic and therapeutic methods in molecular and cellular biology, immunology, microbiology, biochemistry, genomics, and computational biology. She is a member of the firm’s Chemical, Biotech & Pharmaceutical Practice. Prior to joining Foley, Dr. Mangasarian was a partner at a major New York City-based law firm.
Kathleen Kean is a counsel in the firm’s Strategic Technology Transactions and Licensing Practice and member of the Technology and Life Sciences Group. Ms. Kean represents private and public biotech, pharmaceutical, diagnostic and medical device companies in connection with intellectual property, commercial and M&A transactions. Ms. Kean’s experience includes counseling clients in connection with licensing arrangements, collaboration agreements, pre-clinical, clinical and commercial contracts, mergers and acquisitions, corporate restructuring and IP migration transactions. Further, Ms. Kean routinely acts as outside general counsel for biotech companies in managing their licensing and contract needs. Prior to re-joining Goodwin in 2014, Ms. Kean was an in-house attorney at RainDance Technologies, Inc. and was previously in-house at EMC Corporation. Ms. Kean began her legal career at Goodwin in 2004. Prior to attending law school, Ms. Kean worked as a mechanical engineer.
Ms. Kean is a graduate of Manhattan College and Boston University Law School where she was the executive editor of the Boston University Journal of Science & Technology Law
Ms. Kean’s experience includes:
Sage Therapeutics in its strategic collaboration with Shionogi & Co., Ltd. to develop and commercialize SAGE-217 in Japan, Taiwan and South Korea
Wave Life Sciences in the negotiation of a global strategic collaboration with Takeda in central nervous system disorders; upfront of $110 million and potentially more than $2 billion in milestone payments
Nimbus Therapeutics in the negotiation of a strategic alliance with Celgene Corporation in immunology
Fresenius Kabi in its purchase of Merck KGaA’s pipeline of biosimilar candidates for €156 million upfront and up to €500 million in milestones
CRISPR Therapeutics in its development and option agreement with StrideBio for developing novel AAV vectors
Ampersand Capital Partners and 1315 Capital in their acquisition of Genoptix, Inc., a provider of comprehensive testing solutions in hematology and solid tumor molecular profiling, from Novartis Pharmaceuticals Corporation
Nimbus in its sale of Nimbus Apollo and its Acetyl-CoA Carboxylase (ACC) inhibitor program to Gilead Sciences for $400 million and up to an additional $800 million in development milestone payments
Dimension Therapeutics in its gene therapy research collaboration with the University of Pennsylvania
Alkermes in the sale of its manufacturing facility and the manufacturing and royalty revenue associated with products manufactured at the facility and global rights to Recro Pharma, Inc., for $170 million
Tetragenetics in its negotiation of a collaboration with MedImmune for a multi-target ion channel drug discovery program
Licensing of intellectual property assets from research institutions
Keith Zullow, a partner in Goodwin's IP Litigation Group, is a U.S. registered patent attorney with significant trial experience in chemical and pharmaceutical patent litigation. He is also experienced in interference practice and trade secret litigation. Mr. Zullow has worked on cases in various federal district courts throughout the United States, on appeals before the U.S. Court of Appeals for the Federal Circuit and other circuit courts, and is lead counsel on proceedings before the Patent Trial and Appeal Board.
J.D., New York University School of Law, 1994
B.S., Chemical Engineering, Cornell University, 1987 (with distinction)
Mr. Zullow is admitted to practice in New York, as well as before the U.S. Supreme Court, the U.S. Court of Appeals for the Federal Circuit, and the U.S. District Courts for the Southern and Eastern Districts of New York. He is also admitted to practice before the U.S. Patent and Trademark Office.
Clients look to Chris for his extensive background in patent prosecution and counseling, including the development and management of patent portfolios of various sizes. He has a proven record of success in various settings and technology areas.
Chris has substantial experience with a variety of electrical and computer technologies, including display, image sensor, communications, memory and semiconductor. He also has significant experience with business method patents, including those related to financial services and computer applications. His experience is most extensively in prosecution, but also includes opinion counseling and litigation support.
Chris has over twenty five years of experience. In addition to his significant law firm experience, he started his career as a patent examiner, and also worked as senior counsel for a multinational corporation. He lectures and writes regularly on patent issues for the Practicing Law Institute, where he also mentors lawyers on advanced patent prosecution.
Chris’ breadth and depth of experience allow him to successfully navigate through a wide variety of issues in the procurement and enforcement of patent rights. He is also adept at efficiently managing large scale projects and teams, particularly with respect to prosecuting patent portfolios.
Honors & Recognitions
Named Client Service All-Star by BTI Consulting Group, Inc., 2016, 2019
IAM Patent 1000, 2014, 2015, 2016
Member, American Intellectual Property Law Association
Member, Institute of Electrical and Electronics Engineers
Villanova University School of Law, Juris Doctor (J.D.)
Villanova University, Bachelor of Science in Electrical Engineering (B.S.E.E.)
District of Columbia
United States Patent and Trademark Office
Little League Baseball Coach (2003-2009)
Youth Development League Basketball Coach (2004-2012)